CXCR4 and acute myeloid leukemia: Inhibition of AML cell proliferation for at least four patients was seen for anti-bFGF, anti-IL-6, the CCR1/CCR3 inhibitor J113863, and the CCR1 antagonists BX471 and BX513, whereas the CXCR4 inhibitor AMD3100 inhibited MSC24539 proliferation for four patients.